These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 39390498

  • 21. "It's only fatness, it doesn't kill": a qualitative study on perceptions of weight gain from use of dolutegravir-based regimens in women living with HIV in Uganda.
    Alhassan Y, Twimukye A, Malaba T, Myer L, Waitt C, Lamorde M, Colbers A, Reynolds H, Khoo S, Taegtmeyer M.
    BMC Womens Health; 2022 Jun 21; 22(1):246. PubMed ID: 35729541
    [Abstract] [Full Text] [Related]

  • 22. Perceptions relating to body size, weight loss and weight-loss interventions in black South African women: a qualitative study.
    Draper CE, Davidowitz KJ, Goedecke JH.
    Public Health Nutr; 2016 Feb 21; 19(3):548-56. PubMed ID: 26006784
    [Abstract] [Full Text] [Related]

  • 23. ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing.
    Moore CL, Turkova A, Mujuru H, Kekitiinwa A, Lugemwa A, Kityo CM, Barlow-Mosha LN, Cressey TR, Violari A, Variava E, Cotton MF, Archary M, Compagnucci A, Puthanakit T, Behuhuma O, Saϊdi Y, Hakim J, Amuge P, Atwine L, Musiime V, Burger DM, Shakeshaft C, Giaquinto C, Rojo P, Gibb DM, Ford D, ODYSSEY Trial Team.
    BMC Infect Dis; 2021 Jan 04; 21(1):5. PubMed ID: 33446115
    [Abstract] [Full Text] [Related]

  • 24. Time-Restricted Eating Effects on Body Composition and Metabolic Measures in Humans who are Overweight: A Feasibility Study.
    Chow LS, Manoogian ENC, Alvear A, Fleischer JG, Thor H, Dietsche K, Wang Q, Hodges JS, Esch N, Malaeb S, Harindhanavudhi T, Nair KS, Panda S, Mashek DG.
    Obesity (Silver Spring); 2020 May 04; 28(5):860-869. PubMed ID: 32270927
    [Abstract] [Full Text] [Related]

  • 25. Feasibility and Cardiometabolic Effects of Time-Restricted Eating in Patients with Metabolic Syndrome.
    Świątkiewicz I, Nuszkiewicz J, Wróblewska J, Nartowicz M, Sokołowski K, Sutkowy P, Rajewski P, Buczkowski K, Chudzińska M, Manoogian ENC, Taub PR, Woźniak A.
    Nutrients; 2024 Jun 07; 16(12):. PubMed ID: 38931157
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. "No One Needs to be Forced": Qualitative Insights on Competing Priorities between Antiretroviral Therapy and Reproductive Health Planning during the Dolutegravir Rollout.
    Maju M, Hassan SA, Bernard C, Maina M, Thorne JG, Komanapalli SA, Humphrey JM, Kerich C, Changwony S, Jakait B, Wools-Kaloustian K, Patel RC.
    AIDS Behav; 2024 Nov 07; 28(11):3719-3732. PubMed ID: 39083152
    [Abstract] [Full Text] [Related]

  • 29. Interactive weekly mobile phone text messaging plus motivational interviewing in promotion of breastfeeding among women living with HIV in South Africa: study protocol for a randomized controlled trial.
    Zunza M, Cotton MF, Mbuagbaw L, Lester R, Thabane L.
    Trials; 2017 Jul 17; 18(1):331. PubMed ID: 28716146
    [Abstract] [Full Text] [Related]

  • 30. Unexpected interactions between dolutegravir and folate: randomized trial evidence from South Africa.
    Chandiwana NC, Chersich M, Venter WDF, Akpomiemie G, Hill A, Simmons B, Lockman S, Serenata CM, Fairlie L, Moorhouse MA.
    AIDS; 2021 Feb 02; 35(2):205-211. PubMed ID: 33086234
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: a systematic review and meta-analysis protocol.
    Semengue ENJ, Santoro MM, Ndze VN, Dambaya B, Takou D, Teto G, Nka AD, Fabeni L, Wiyeh A, Ceccherini-Silberstein F, Colizzi V, Perno CF, Fokam J.
    Syst Rev; 2020 Apr 25; 9(1):93. PubMed ID: 32334643
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Blood pressure increases are associated with weight gain and not antiretroviral regimen or kidney function: a secondary analysis from the ADVANCE trial in South Africa.
    Manne-Goehler J, Fabian J, Sokhela S, Akpomiemie G, Rahim N, Lalla-Edward ST, Brennan AT, Siedner MJ, Hill A, Venter WDF.
    J Int AIDS Soc; 2024 Jul 25; 27(7):e26268. PubMed ID: 38978403
    [Abstract] [Full Text] [Related]

  • 35. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
    Spencer L, Rollo M, Hauck Y, MacDonald-Wicks L, Wood L, Hutchesson M, Giglia R, Smith R, Collins C.
    JBI Database System Rev Implement Rep; 2015 Jan 25; 13(1):88-98. PubMed ID: 26447010
    [Abstract] [Full Text] [Related]

  • 36. D3/Penta 21 clinical trial design: A randomised non-inferiority trial with nested drug licensing substudy to assess dolutegravir and lamivudine fixed dose formulations for the maintenance of virological suppression in children with HIV-1 infection, aged 2 to 15 years.
    Turkova A, Chan MK, Kityo C, Kekitiinwa AR, Musoke P, Violari A, Variava E, Archary M, Cressey TR, Chalermpantmetagul S, Sawasdichai K, Ounchanum P, Kanjanavanit S, Srirojana S, Srirompotong U, Welch S, Bamford A, Epalza C, Fortuny C, Colbers A, Nastouli E, Walker S, Carr D, Conway M, Spyer MJ, Parkar N, White I, Nardone A, Thomason MJ, Ferrand RA, Giaquinto C, Ford D, D3 trial team.
    Contemp Clin Trials; 2024 Jul 25; 142():107540. PubMed ID: 38636725
    [Abstract] [Full Text] [Related]

  • 37. Clinical, pharmacological, and qualitative characterization of drug-drug interactions in pregnant women initiating HIV therapy in Sub-Saharan Africa.
    Kiiza D, Rostami-Hochaghan D, Alhassan Y, Seden K, Reynolds H, Kaboggoza JP, Taegtmeyer M, Chen T, Challenger E, Malaba T, Wang D, Else L, Hern F, Sharp J, Neary M, Dilly Penchala S, Waitt C, Orrell C, Colbers A, Myer L, Owen A, Rannard S, Khoo S, Lamorde M.
    J Antimicrob Chemother; 2024 Sep 03; 79(9):2334-2342. PubMed ID: 38997229
    [Abstract] [Full Text] [Related]

  • 38. Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial.
    Venter WDF, Sokhela S, Simmons B, Moorhouse M, Fairlie L, Mashabane N, Serenata C, Akpomiemie G, Masenya M, Qavi A, Chandiwana N, McCann K, Norris S, Chersich M, Maartens G, Lalla-Edward S, Vos A, Clayden P, Abrams E, Arulappan N, Hill A.
    Lancet HIV; 2020 Oct 03; 7(10):e666-e676. PubMed ID: 33010240
    [Abstract] [Full Text] [Related]

  • 39. Exclusive breast-feeding promotion among HIV-infected women in South Africa: an Information-Motivation-Behavioural Skills model-based pilot intervention.
    Tuthill EL, Butler LM, Pellowski JA, McGrath JM, Cusson RM, Gable RK, Fisher JD.
    Public Health Nutr; 2017 Jun 03; 20(8):1481-1490. PubMed ID: 28173897
    [Abstract] [Full Text] [Related]

  • 40. Comparative Effects of Efavirenz and Dolutegravir on Metabolomic and Inflammatory Profiles, and Platelet Activation of People Living with HIV: A Pilot Study.
    Roux CG, Mason S, du Toit LDV, Nel JG, Rossouw TM, Steel HC.
    Viruses; 2024 Sep 14; 16(9):. PubMed ID: 39339938
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.